Mass Tort brief
Meta's $17.1B Youth Settlement and Federal Bellwether Showdowns
Tech giants and pharmaceutical firms face pivotal multidistrict legal resolutions as major settlements resolve billions in statutory liability.
Mass Tort
Mass Tort
Walmart settled its multi-billion-dollar federal opioid lawsuit for $50M — ending a 6-year legal battle with no admission of wrongdoing.
BackgroundThe Justice Department sued Walmart in December 2020, alleging its pharmacists filled thousands of suspicious opioid orders while ignoring warning flags from high-volume prescribers. Retail pharmacy chains faced extensive government claims over their roles in prescription drug distribution.
- The $50 million payout represents a tiny fraction of the multi-billion-dollar statutory penalties originally sought by federal prosecutors.
- Walmart described the settlement payout as financially immaterial relative to corporate earnings in recent SEC disclosures.
- The agreement mandates enhanced compliance monitoring across pharmacy networks and establishes a hotline for reporting suspicious prescriptions.
Mass Tort
The first federal infant formula bellwether trial is underway — testing manufacturer liability for severe intestinal injuries in premature infants.
BackgroundNecrotizing enterocolitis is a severe gastrointestinal illness affecting premature infants. Hundreds of product liability lawsuits allege formula manufacturers failed to warn hospital neonatal units that cow's milk formulas increase injury risks relative to human milk.
- The lead bellwether case Alexis Inman v. Mead Johnson & Company opened arguments following key pretrial evidentiary rulings.
- Pretrial rulings limited expert testimony while allowing claims regarding inadequate hospital warning labels to proceed before the jury.
- Jury verdicts in this initial bellwether will set settlement valuations across hundreds of pending federal formula injury suits.
Mass Tort
The judicial panel is moving to consolidate spinal cord stimulator injury claims — testing preemption defenses across medical device makers.
BackgroundSpinal cord stimulators are implanted medical devices that deliver electrical impulses to manage chronic pain. The JPML previously consolidated similar medical device injury claims against Boston Scientific under MDL No. 3181.
- Lawsuits allege defective battery housing and wire migration caused internal electrical shocks and organ damage requiring corrective surgery.
- Device manufacturers contend federal premarket approval by the FDA preempts state-level product liability claims.
- A consolidation ruling on September 24 would centralize dozens of individual state lawsuits into unified federal court dockets.
Mass Tort
Mass Tort